The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Professional NewsFull Access

Confidentiality: When Does It Give Way to Other Ethical Imperatives?

Published Online:https://doi.org/10.1176/appi.pn.2016.9a12

Abstract

One expert describes a tension between the enduring psychiatric ethical principle of confidentiality and that of “paternalism,” the ethical imperative to do what psychiatrists think is best for patients.

When 21-year-old Susanna Gabay left a Eugene, Oregon, hospital in early April 2010 after being treated for a psychotic episode—apparently successfully—she returned to her apartment in town with an appointment to see a community psychiatrist a month later, on May 5.

But Susanna never made it to the follow-up appointment, and on May 6 she took her own life. Her parents, Jerry and Susan Gabay, told Psychiatric News that though Susanna had signed an authorization allowing release of information to her family, they were in fact given scant information about the nature of her condition and, crucially, were not told of her risk for suicide.

Communicating With Family Members and Caregivers

The Oregon Council on Child and Adolescent Psychiatry, assisted by Jerry and Susan Gabay, issued “Suicide Prevention in Youth and Young Adults: Communicating With Families Saves Lives—A Checklist for Health Providers and Mental Health Practitioners.” The checklist includes these steps:

  • Complete a comprehensive risk assessment including patient interview, record review, and solicitation of information from family/parents. If you do not feel qualified to complete a comprehensive risk assessment, refer the patient for urgent evaluation and verify completion.

  • If the patient is 18 or older, or if you believe confidentiality is required by law or common medical practice, seek an authorization to release information for the family/parents or document a compelling reason not to do so. Be assertive and persuasive in obtaining this authorization.

  • Interview the family to obtain additional history about the patient and to determine what the family/parents already know about the illness/need for treatment. An authorization is not necessary to do this.

  • Obtain authorizations to obtain information from all previous treatment providers and promptly request treatment records, including psychotherapy notes, psychiatric treatment, and relevant medical records.

  • Review the medical records carefully to gain a comprehensive knowledge of risk factors for the patient.

  • Following the initial evaluation, communicate with the patient and the family/parents regarding diagnoses, treatment recommendations, and safety issues. Do not assume they know anything about the nature of mental illness, treatment, risk factors, or community resources.

  • Explicitly inform the family in the presence of the patient of all safety issues, including risk factors for suicide and what steps to take if danger exists, such as ridding the home of firearms/other means of self-harm and creating a plan to monitor and support the patient.

  • Discuss available community resources to help the family and patient, including resources for case management, support groups, improving mental health at home, and other relevant factors.

  • Coordinate provision of care when a patient transitions from one level of care to another, or from one provider to another.

  • Involve the patient and family in the planning process, including discussion of interim safety plan.

  • Assure follow-up is in place with a specific timely appointment.

  • Assure that the follow-up provider has full knowledge of history and risk issues/records.

  • Confirm that the patient has attended the follow-up appointment.

The checklist and other resources can be accessed here.

The tragedy of Susanna’s death may have stemmed from the shortened hospital stays and failure to coordinate follow-up care that have been endemic in a fragmented mental health care system. But Jerry and Susan also believe the lack of communication from the hospital and clinicians who treated her—despite Susanna’s authorization—left them blind to the seriousness of her condition. They say her death is attributable in part to a “culture of silence” among clinicians about sharing information with family members and caregivers.

The Gabays believe clinicians are too inclined, by training and long tradition, to err on the side of caution about sharing information—a tendency abetted by what they also believe is an overly-restrictive interpretation of the Privacy Rule within the Health Insurance Portability and Accountability Act (HIPAA).

Since their daughter’s death, the Gabays have championed the rights of family members and caregivers to have access to information about loved ones being treated for serious mental illness. They were instrumental in the passage of a law last year by the Oregon legislature that clarifies conditions under which protected health information may be disclosed by a health care provider, consistent with HIPAA, without obtaining an authorization from the individual and without incurring liability.

“At minimum, providers must be encouraged to seek authorizations to communicate with appropriate supporters of the patient and then actually communicate,” Jerry, a board member of the Oregon National Alliance on Mental Illness, told lawmakers during testimony on the bill.

The Gabays also helped to develop, with the support of the Oregon Council on Child and Adolescent Psychiatry and the Oregon Psychiatric Physicians Association, resource materials to guide both clinicians and family members about the circumstances under which information—and what kind of information—can and should be divulged. In an interview with Psychiatric News, Susan Gabay said, “The responsibility to protect the safety of the patient trumps confidentiality.”

Navigating Between Confidentiality and “Paternalism”

Confidentiality is a bedrock ethical principle of psychiatry: the nature of mental illness and the suffering that brings patients to a psychiatrist render what transpires between therapist and patient especially sacrosanct—and in some people’s opinion, inviolable.

But this longstanding ethical principle can come into conflict with a recovery movement that has empowered family members and caregivers to expect that clinicians will share information vital to their loved one’s recovery. The tension between these two conflicting precepts has been heightened as well by publicity about acts of violence committed by individuals treated for mental illness.

In the wake of the 2012 shooting at Sandy Hook Elementary School in Newtown, Connecticut, and subsequent Congressional hearings during which clinicians expressed confusion about what the HIPAA Privacy Rule allows or does not allow, the Office of Civil Rights in the Department of Health and Human Services issued a clarification, underscoring that clinicians could indeed disclose information about a patient’s treatment under certain conditions (Psychiatric News, March 21, 2014).

Additionally, among the provisions in the Helping Families in Mental Health Crisis Act, sponsored by Rep. Tim Murphy (R.-Pa.), is one that calls on the secretary of Health and Human Services to promulgate final regulations clarifying circumstances under which a clinician may disclose the protected health information of a patient with mental illness to family. The bill was approved by the House 422-2 on July 6.

In an interview with Psychiatric News, Steven Kenny Hoge, M.D., chair of APA’s Council on Psychiatry and Law, described the dilemma for clinicians as a tension between the demands of confidentiality and the competing ethical principle of “paternalism”—a term of art in medical ethics denoting the duty to do what is best for the patient.

What Would You Do?

You are treating a patient with bipolar disorder and a past history of suicide attempt. He appears to be stable and doing well, but he tells you that recently he has stopped taking his medication. His parents are anxious to know of his progress, but the patient is 25 years old and has not authorized release of information about his treatment to family members. Would you disclose to the parents that the patient has ceased taking medication? What factors would you weigh in making your decision?

Write to Psychiatric News and tell us how you would deal with this clinical dilemma. We will publish a selection of responses, with commentary from experts. Send your responses to [email protected].

“Imagine a patient who is a young man with schizophrenia. He is intermittently psychotic but denies that he is mentally ill and tells the clinician ‘My parents want to view me as ill because that’s better for them. I don’t want you telling my parents anything.’ ”

“In fact,” Hoge said, “the parents or caregivers may be providing a great deal of support and structure with regard to appointments, taking medications, and otherwise helping the patient adhere to treatment. Historically, pre-HIPAA many psychiatrists would take a more paternalistic approach that, at least in some cases, would cause the clinician not to follow the patient’s explicit directive.

“That’s become complicated by what appears to be a relatively rigid regulatory scheme in HIPAA that suggests to many clinicians that it is not only unethical but illegal to take this more paternalistic approach. In the span of my career, medicine has gone down a path that has de-emphasized paternalism. But I continue to believe that our primary duty as physicians is to do what is best for the patient and that we should have both professional ethics and laws that support physicians in doing what is best for their patients.”

Past APA President Paul Appelbaum, M.D., said there are other instances where the boundary separating confidentiality and the imperative to act in the patient’s interest may not at all be a bright line, such as when a patient is doing or not doing something that undermines treatment—not taking medication regularly or abusing substances—about which family members might be usefully informed.

“In the current regulatory structure, that’s hard to do without consent,” he told Psychiatric News. “The first option for any clinician is to try to get consent. The regulations do allow disclosure of information to people assisting in the care of the patient if the patient is aware of it and doesn’t object. You don’t actually need affirmative written consent.”

Appelbaum is the Elizabeth K. Dollard Professor of Psychiatry, Medicine, and Law and director of the Division of Law, Ethics, and Psychiatry at Columbia University.

Ultimately, he said, clinicians must choose between confidentiality or paternalism on a case-by-case basis. “Family members play an important role in recovery, which is made more difficult when they have an adult family member about whom they are unable to obtain any information because the patient has told the clinician not to talk to family members. All of us have a strong impulse to act on the patient’s best interest when they lack some degree of insight or capacity to make a truly informed choice.

“But there is something to be said on the other side as well—that to single out psychiatry patients for a lesser degree of protection than other general medical patients are afforded seems inherently discriminatory,” Appelbaum added. “That’s something we ought to consider seriously when thinking about changes to the law.”

Since their daughter’s death, Jerry and Susan Gabay have made prevention of suicide, and the empowerment of families and caregivers, a mission. They say they respect the importance of confidentiality—certainly regarding the actual content of psychotherapy—but they argue that the clinician’s ability to navigate the boundaries between confidentiality and communication with family is in the nature of the title of “professional.”

“There is, of course, a tension between confidentiality and the value of sharing information,” Jerry Gabay said. “But there is also a reason clinicians are called professionals and not functionaries—because they can make those determinations responsibly.” ■

Click here for part 2 of this article. Also, APA has extensive resources for members about HIPAA and the Privacy Rule here. The text of the legislation approved in Oregon can be accessed here.